SDS
Quik Stik® Mini Twist Paint Marker White, Yellow, Red
according to Federal Register / Vol. 77, No. 58 / Monday, March 26, 2012 / Rules and Regulations
according to Canadian Hazardous Products Regulations (HPR)
Date of issue: 04/13/2015
Version: 1.0
13/04/2015
EN (English)
SDS Ref.: LACO1504017
1/1
SECTION 1: Identification of the substance/mixture and of the company/undertaking
1.1. Product identifier
Product form
:
Mixture
Product name
:
Quik Stik® Mini Twist Paint Marker White, Yellow, Red
1.2. Relevant identified uses of the substance or mixture and uses advised against
Use of the substance/mixture
:
Marking.
1.3. Details of the supplier of the safety data sheet
LA-CO Industries, Inc.
1201 Pratt Boulevard
Elk Grove Village, IL. 60007-5746
Phone: (847) 956-7600
Fax: (847) 956-9885
E-mail: customer_service@laco.com
1.4. Emergency telephone number
Emergency number
:
24-hour emergency: CHEMTREC- U.S. : 1-800-424-9300 International: +1-703-527-3887
SECTION 2: Hazards identification
2.1. Classification of the substance or mixture
Classification in accordance with the Globally Harmonized Standard
Skin Irrit. 2
H315
Eye Irrit. 2A
H319
Full text of H-phrases: see section 16
2.2 Label elements
GHS-US labelling
Hazard pictograms (GHS-US)
:
GHS07
Signal word (GHS-US)
:
Warning
Hazard statements (GHS-US)
:
H315 - Causes skin irritation
H319 - Causes serious eye irritation
Precautionary statements (GHS-US)
:
P264 - Wash hands thoroughly after handling
P280 - Wear eye protection, protective gloves
P302+P352 - If on skin: Wash with plenty of water
P305+P351+P338 - If in eyes: Rinse cautiously with water for several minutes. Remove contact
lenses, if present and easy to do. Continue rinsing
P321 - Specific treatment (see First aid measures on this label)
P332+P313 - If skin irritation occurs: Get medical advice/attention
P337+P313 - If eye irritation persists: Get medical advice/attention
P362 - Take off contaminated clothing and wash before reuse
2.3. Other hazards
No additional information available
2.4 Unknown acute toxicity (GHS US)
31.5 percent of the mixture consists of ingredient(s) of unknown acute toxicity (Oral)
31.5 percent of the mixture consists of ingredient(s) of unknown acute toxicity (Dermal)
31.5 percent of the mixture consists of ingredient(s) of unknown acute toxicity (Inhalation (Dust/Mist))
SECTION 3: Composition/information on ingredients